Rivaxo™

Rivaxo™

Therapeutic Segment: Anti-Coagulant

Generic Name: Rivaroxaban

Indication:

For the treatment of the following conditions:

  • Reduction of risk of stroke and systemic embolism in non-valvular atrial fibrillation.
  • Deep Vein Thrombosis (DVT)
  • Pulmonary Embolism (PE)
  • Reduction in the risk of recurrence of deep vein thrombosis and of pulmonary embolism following initial 6 months treatment for DVT and/or PE.
  • Prophylaxis of deep vein thrombosis which may lead to PE in patients undergoing knee or hip replacement surgery.

Available as:

  • 10MG
  • 15MG
  • 20MG